AMGEN INC.

THOUSAND OAKS, CA US

1. 20090275602 Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of use 11-05-2009
2. 20090234106 ANTI-ACTIVIN A ANTIBODIES AND USES THEREOF 09-17-2009
3. 20090221789 Crystalline Polypeptides - Crystalline formulations of therapeutic peptides, along with methods for making and using the same, are provided 09-03-2009
4. 20090186822 Thrombopoietic Compounds - field of compounds, especially peptides or polypeptides, that have thrombopoietic activity 07-23-2009
5. 20090173876 Method of detecting and/or measuring hepcidin in a sample 07-09-2009
6. 20090155274 HUMAN ANTI-NGF NEUTRALIZING ANTIBODIES AS SELECTIVE NGF PATHWAY INHIBITORS 06-18-2009
7. 20090123975 FEED MEDIA - The invention provides stable feed media containing pyruvate and methods for stabilizing feed media by adding pyruvate 05-14-2009
8. 20090117101 HEH4 Molecules and Uses Thereof - HEH4 polypeptides and nucleic acid molecules encoding the same 05-07-2009
9. 20090105174 NUCLEIC ACIDS HYBRIDIZABLE TO MICRO RNA AND PRECURSORS THEREOF 04-23-2009
10. 20090098575 The Human E3alpha Ubiquitin Ligase Family 04-16-2009
11. 20090081182 Modified Lecithin-Cholesterol Acyltransferase Enzymes 03-26-2009
12. 20090074763 METHOD FOR INHIBITING BONE RESORPTION - The invention is directed to a method of inhibiting bone resorption 03-19-2009
13. 20090054323 Specific Binding Agents of Human Angiopoietin-2 02-26-2009
14. 20090053242 Thrombopoietic compounds - use of compounds, especially peptides or polypeptides, that have thrombopoietic activity, and pegylated forms thereof 02-26-2009
15. 20090036478 Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of use 02-05-2009
16. 20090030005 Combinations for the treatment of cancer 01-29-2009
17. 20080318946 Di-amino-substituted heterocyclic compounds and methods of use 12-25-2008
18. 20080305074 Stem cell factor - Novel stem cell factors, oligonucleotides encoding the same, and methods of production, are disclosed 12-11-2008
19. 20080287659 G-CSF Conjugates - Physiologically active PEG-GCSF conjugates having a formula as follows: are described as well as compositions containing a mixture of 11-20-2008
20. 20080254020 Therapeutic Peptides - compounds that exhibit improved bioefficacy in multidose administration 10-16-2008
21. 20080249090 Substituted pyridone compounds and methods of use 10-09-2008
22. 20080241154 Isolation, Identification and Characterization of tmst2, a Novel Member of the TNF-Receptor Supergene Family 10-02-2008
23. 20080234470 KCNB: A NOVEL POTASSIUM CHANNEL PROTEIN - nucleic acid and protein sequences for a novel potassium channel protein, KCNB 09-25-2008
24. 20080227779 Heterocyclic compounds and methods of use 09-18-2008
25. 20080213277 HEPCIDIN, HEPCIDIN ANTAGONISTS AND METHODS OF USE 09-04-2008
26. 20080206184 Chemically Modified Protein Compositions and Methods 08-28-2008